ALEXANDRIA, Va., May 25 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'GLYTUZUMAB' in its latest official gazette. The trademark application with the serial number 87942924 was filed on May 31, 2018.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical and medical preparations for the diagnosis, treatment and prevention of cancer, oncological disorders, autoimmune diseases, and inflammatory diseases
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Minomic International Ltd. Suite 2, Ground Floor 75 Talavera Road Macquarie Park New South Wales AU AUSTRALIA 2113 11 COMPANY
Disclaimer: Curated by HT Syndication....